The NCI60 panel of cancer cell lines was developed in the late 1980s to facilitate in vitro assay-based drug discovery. As genomic and drug response data has accumulated on the individual NCI60 cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback